Malorye Allison Branca

3 days ago | insideprecisionmedicine.com | Malorye Allison Branca

The startling rise in colorectal cancer (CRC) among younger people has led to an intensive search for a cause of this trend. A new study led by researchers from the German Cancer Research Center (DKFZ) suggests alcohol consumption and smoking are significant risk factors for early-onset CRC (EOCRC). The authors say awareness about this link should be part of prevention efforts. The report appears in Clinical Colorectal Cancer and the lead author is Janine Wieser of the DKFZ.

1 week ago | insideprecisionmedicine.com | Malorye Allison Branca

The case of a sperm donor who was later found to be carrying a previously undocumented cancer-causing variant has sparked discussion about further regulating gamete donation in Europe. The donor is apparently in good health, but his biological children are at risk of Li-Fraumeni syndrome, which heightens cancer risk. Of 67 children from 46 families in eight European countries, the variant was found in 23 and cancer found in 10, to date.

2 weeks ago | insideprecisionmedicine.com | Malorye Allison Branca

An ultra-rapid method of genetically diagnosing brain tumors has been developed by scientists at the University of Nottingham and clinicians at Nottingham University Hospitals NHS Trust (NUH). Their approach, could cut the time it takes to classify brain tumors to as little as two hours, where it typically takes from 6-8 weeks. The groundbreaking technique is detailed in a new study published yesterday in Neuro-Oncology.

3 weeks ago | insideprecisionmedicine.com | Malorye Allison Branca

Most oncologists are seeing more advanced cancers and think screening barriers are the leading cause of this trend, according to a new report based on a survey conducted by the Harris Poll on behalf of Quest Diagnostics. The survey also found that 94% of oncologists thought circulating tumor DNA (ctDNA) minimal residual disease (MRD) testing could reduce diagnosis delays in cancer recurrence. But they anticipated significant hurdles to wide adoption of this type of testing.

3 weeks ago | insideprecisionmedicine.com | Malorye Allison Branca

The largest study ever conducted on individuals with cardiovascular disease finds that in those with atherosclerotic cardiovascular disease (ASCVD), risk of recurrent cardiovascular events continues to rise across all ascending levels of Lp(a), with no indication of risk plateauing. This finding is contrary to earlier research. These findings were presented on May 7th at the European Atherosclerosis Society (EAS). They were simultaneously published in the European Heart Journal.